Chemours settles PFAS case for about $450 million

Chemours has agreed to a multi-state settlement totaling about $450 million to resolve alleged environmental violations involving per- and polyfluoroalkyl substances, commonly known as PFAS or "forever chemicals." The settlement was reached with U.S. federal authorities and state officials and is structured as a comprehensive enforcement resolution against the manufacturer. It addresses long-running allegations that Chemours’ operations led to PFAS contamination affecting waterways and nearby communities.

As part of the financial terms, Chemours will pay a $22.5 million civil penalty. In addition, the company will fund approximately $90 million in mitigation projects over a 15-year period. These measures are intended to reduce ongoing PFAS impacts and remediate contamination linked to the company’s facilities.

A central element of the settlement is Chemours’ commitment to support access to safe drinking water in affected areas. The company will fund an estimated $280 million program to provide treated or alternative drinking water to communities near its facilities in West Virginia and New Jersey. This program is expected to extend for more than a decade and is designed to address PFAS detected in local water supplies.

The drinking water program forms part of the injunctive relief imposed under the consent decree. It complements other technical and infrastructure upgrades that Chemours must undertake to limit future PFAS migration into groundwater and surface water around its sites.

The settlement requires Chemours to install PFAS pollution controls at its West Virginia facility at an estimated cost of $60 million. The consent decree specifies 14 individual projects at this plant, reflecting a detailed plan for reducing PFAS releases into the surrounding environment. These obligations extend beyond penalties to impose ongoing operational changes.

Among the mandated projects are treatment systems that use granulated activated carbon. These systems are intended to reduce PFAS concentrations in wastewater, stormwater, and groundwater originating from the West Virginia site. Collectively, the projects are aimed at preventing further contamination while addressing legacy discharges.

Government filings in connection with the agreement allege that Chemours facilities discharged PFAS into the Ohio River, the Cape Fear River, and the Delaware River. The alleged conduct was said to have continued for more than a decade and involved violations of multiple environmental statutes. The settlement resolves claimed breaches of the Clean Water Act, the Resource Conservation and Recovery Act, the Toxic Substances Control Act, and relevant state water pollution laws.

Officials have described this as the first comprehensive federal settlement resolving enforcement claims against a PFAS manufacturer. While it imposes substantial financial and operational obligations, the agreement provides Chemours with clarity over these specific legacy claims, subject to the company meeting its long-term commitments under the consent decree.

The agreement permits Chemours to continue manufacturing PFAS for certain commercial and military applications. However, ongoing production is conditioned on the new controls, treatment requirements, and mitigation programs set out in the settlement. These measures are designed to limit future PFAS discharges while maintaining supply for uses deemed important.

By combining penalties, capital spending on controls, and long-term community support, the settlement reshapes how Chemours must manage PFAS across key facilities. It underscores increasing regulatory scrutiny of PFAS manufacturing while outlining a framework intended to reduce environmental and public health risks over time.